Secondary and Safety Outcomes | Part one | Â | Part two | ||||
---|---|---|---|---|---|---|---|
RCA-one (n = 39) | RCA-two (n = 38) | P value |  | Saline (n = 31) | RCA-two (n = 33) | P value | |
Serious clotting scores (=3) (%) | 20 (51.28) | 5 (13.16) | < 0.001 |  | 15 (48.39) | 6 (18.18) | 0.016 |
Arterial expansion chamber (%) | 0 (0.00) | 0 (0.00) | 1.000 | Â | 1 (3.23) | 0 (0.00) | 0.484 |
Dialyzer (%) | 2 (5.13) | 1 (2.63) | 0.289 | Â | 1 (3.23) | 1 (3.03) | 1.000 |
Venous expansion chamber (%) | 18 (46.15) | 4 (10.53) | < 0.001 |  | 13 (41.94) | 6 (18.18) | 0.038 |
Urea clearance | |||||||
KT/V value, median (IQR) (%) | 1.25 (1.01–1.65) | 1.24 (1.11–1.42) | 0.792 |  | 1.13 (0.79–1.41) | 1.41 (1.27–1.48) | 0.007 |
URR value, median (IQR), % | 0.65 (0.62–0.75) | 0.66 (0.61–0.71) | 0.488 |  | 0.62 (0.51–0.70) | 0.70 (0.66–0.71) | 0.005 |
AEs | 8 (20.51) | 10 (26.31) | 0.547 | Â | 4 (12.90) | 7 (21.21) | 0.379 |
Dizzy, n (%) | 0 (0.00) | 1 (2.63) | 0.494 | Â | 0 (0.00) | 1 (3.03) | 1.000 |
Convulsions, n (%) | 0 (0.00) | 1 (2.63) | 0.494 | Â | 1 (3.23) | 1 (3.03) | 1.000 |
Hypoglycemia, n (%) | 1 (2.56) | 0 (0.00) | 1.000 | Â | 2 (6.45) | 1 (3.03) | 0.607 |
Hypotension, n (%) | 4 (10.26) | 6 (15.79) | 0.517 | Â | 1 (3.23) | 2 (6.06) | 1.000 |
Chest tightness, n (%) | 3 (7.69) | 1 (2.63) | 0.615 | Â | 0 (0.00) | 0 (0.00) | 1.000 |
Other, n (%) | 0 (0.00) | 1 (2.63) | 0.494 | Â | 0 (0.00) | 2 (6.06) | 0.493 |